Bafna Pharmaceuticals

Quarterly
Consolidated
ParticularsJun '18Sep '18Jun '19Sep '19
Revenue11.958.817.1512.16
Expenses0.8310.0310.8612.70
EBITDA0.000.15-2.560.21
EBIT0.00-0.60-3.58-0.51
Profit Before Tax-3.52-1.23-3.71-0.55
Net Profit-3.52-1.28-2.13-0.59
Financial Ratios
Operating Profit Margin-14.48%1.70%-37.52%1.90%
Net Profit Margin-29.46%-14.48%-31.09%-5.10%
Earning Per Share (Diluted)0.00-0.80-0.90-0.25
Dividends Per Share0.000.000.000.00